Daily Roundup

SKS.ASX PDI.ASX IMC.ASX NWH.ASX PDN.ASX

Expansion in the Data Centre Sector for SKS Technologies

SKS Technologies Group Ltd has secured an additional $80 million contract for a data centre project in Melbourne, bringing the total contract value to $210 million. The project involves the design and construction of critical electrical systems and infrastructure for a hyperscale data centre facility. This expanded scope includes additional medium and high voltage works, with the project expected to be completed in the third quarter of 2027.

The increased contract value demonstrates SKS Technologies' ability to convert pipeline opportunities into awarded projects and indicates broader market confidence in the business's capability to reliably deliver mission-critical projects at scale. The company is now a fixture in the Victorian data centre market, having completed projects for most of the global data centre hyperscalers. SKS also plans to build momentum in the New South Wales data centre market, recently securing a $3 million contract for an electrical infrastructure upgrade.

Predictive Discovery and Robex Complete Merger

Predictive Discovery Limited (PDI) and Robex Resources Inc. (Robex) have successfully completed their merger, creating a leading West African gold production and development company. The combined entity is targeting production of more than 400,000 ounces of gold per annum by 2029, based on the Bankan Project's estimated production of 272,000 ounces and the Kiniero Project's estimated production of 155,000 ounces.

Effective as of 15 April 2026, PDI, through its wholly owned subsidiary, acquired all the issued and outstanding common shares of Robex. Former holders of Robex Shares and Robex Chess Depositary Interests are entitled to receive 7.862 ordinary shares in the capital of PDI for each Robex Share or Robex CDI held. PDI has become a reporting issuer in each of the Provinces and Territories of Canada, with PDI Shares expected to commence trading on the Toronto Stock Exchange and the Australian Securities Exchange later this month.

Immuron Reports Double-Digit Sales Growth

Immuron Limited, an Australian biopharmaceutical company, has reported continued sales growth of its over-the-counter immune supplement Travelan. Global Q3 sales were AUD$1.5 million, up 16% on the prior comparative period. Year-to-date March 2026 sales were AUD$5.7 million, up 7% on the prior comparative period.

The sales growth was driven by increased brand awareness, consumer promotions, new store listings, and increased travel in key markets. In Australia, Q3 sales were AUD$0.9 million, up 15% on the prior comparative period, while year-to-date March 2026 sales were AUD$4.2 million, up 14%. In Canada, Q3 sales were AUD$0.1 million, up over 100% on the prior comparative period, with an 82% increase on the prior quarter, driven by initial sales to the leading pharmacy group Jean Coutu in Quebec.

Fredon Secures $160 Million in Contract Awards for NRW Holdings

NRW Holdings' wholly owned subsidiary Fredon has secured a suite of electrical and mechanical contracts worth around $160 million, reinforcing its capabilities across infrastructure, health, and renewables sectors.

The contracts include a $110 million electrical package on a major Commonwealth infrastructure project in Northern Australia, a $23 million design and construct contract for electrical services in the Festival Towers Project in South Australia, and a $24 million mechanical contract for the Mt Barker Hospital Project, also in South Australia. Fredon has also secured additional contracts for electric bus charging infrastructure and electrical systems in South Australia and Victoria.

NRW's CEO Jules Pemberton expressed excitement over the growth opportunities being harnessed by Fredon since its acquisition, particularly in sectors where demand for specialized electrical capability has increased, such as infrastructure and renewables.

Paladin Energy Revises Guidance for Langer Heinrich Mine

Paladin Energy Ltd has revised its FY2026 guidance for the Langer Heinrich Mine (LHM), increasing the production range to 4.5 - 4.8Mlb U3O8 due to strong operational performance in the first nine months. The capital and exploration expenditure guidance has also been reduced to US$15 million to US$17 million, down from the previous range of US$26 million to US$32 million.

The LHM ramp-up and transition to full mining operations have progressed well, with year-to-date production of 3.6Mlb U3O8. Paladin continues to expect LHM to transition to full mining and processing plant operations by the end of FY2026. The cost of production is expected to materially align with previous guidance of US$44 - US$48 per pound.